Insiders / Fitzgerald Kevin Joseph

Fitzgerald Kevin Joseph

CIK 1886431personinsider
Companies
2
First seen
Jan 14, 2026
Last activity
Mar 6, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Alnylam Pharmaceuticals Inc · ALNYExecutive20,56925,26460
Ovid Therapeutics Inc. · OVIDDirector65,0001

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Alnylam Pharmaceuticals IncCommon Stock20,569Mar 5, 2026
Alnylam Pharmaceuticals IncStock Option (right to buy)Derivative8,105Mar 2, 2026
Ovid Therapeutics Inc.Employee Stock Option (Right to Buy)Derivative65,000Feb 26, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Feb 17, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$677.5K-2K
-8.76%
21,264
0.02% of shares
medium
Feb 13, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$607.4K-2K
-7.75%
23,305
0.02% of shares
medium
Jan 13, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$238.3K-644
-2.83%
22,151
0.02% of shares
medium
Mar 3, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$231.4K-722
-3.15%
22,219
0.02% of shares
medium
Jan 13, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$207.2K-562
-2.41%
22,795
0.02% of shares
medium
Jan 13, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$180.1K-485
-2.19%
21,666
0.02% of shares
medium
Mar 2, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$128.1K-392
-1.59%
24,323
0.02% of shares
medium
Mar 3, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$115.4K-359
-1.62%
21,860
0.02% of shares
medium
Mar 2, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$107.8K-329
-1.35%
23,994
0.02% of shares
medium
Jan 13, 2026SellALNY
Alnylam Pharmaceuticals Inc
Common Stock
$104.4K-280
-1.29%
21,386
0.02% of shares
medium